Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Quantitative trait mapping reveals a regulatory axis involving peroxisome proliferator-activated receptors, PRDM16, transforming growth factor-β2 and FLT3 in hematopoiesis.

Avagyan S, Aguilo F, Kamezaki K, Snoeck HW.

Blood. 2011 Dec 1;118(23):6078-86. doi: 10.1182/blood-2011-07-365080. Epub 2011 Oct 3.

3.

Prdm16 is a physiologic regulator of hematopoietic stem cells.

Aguilo F, Avagyan S, Labar A, Sevilla A, Lee DF, Kumar P, Lemischka IR, Zhou BY, Snoeck HW.

Blood. 2011 May 12;117(19):5057-66. doi: 10.1182/blood-2010-08-300145. Epub 2011 Feb 22.

6.

Transforming growth factor-beta2 is involved in quantitative genetic variation in thymic involution.

Kumar R, Langer JC, Snoeck HW.

Blood. 2006 Mar 1;107(5):1974-9. Epub 2005 Nov 10.

8.

FLT3 receptor and ligand are dispensable for maintenance and posttransplantation expansion of mouse hematopoietic stem cells.

Buza-Vidas N, Cheng M, Duarte S, Charoudeh HN, Jacobsen SE, Sitnicka E.

Blood. 2009 Apr 9;113(15):3453-60. doi: 10.1182/blood-2008-08-174060. Epub 2009 Feb 2.

9.

Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.

Drexler HG.

Leukemia. 1996 Apr;10(4):588-99. Review.

PMID:
8618433
10.

A quantitative trait locus on chr.4 regulates thymic involution.

Kumar R, Avagyan S, Snoeck HW.

J Gerontol A Biol Sci Med Sci. 2010 Jun;65(6):620-5. doi: 10.1093/gerona/glq041. Epub 2010 Apr 6.

11.

Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells.

Ahdjoudj S, Kaabeche K, Holy X, Fromigué O, Modrowski D, Zérath E, Marie PJ.

Exp Cell Res. 2005 Feb 1;303(1):138-47.

PMID:
15572034
12.

Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells.

Brun AC, Björnsson JM, Magnusson M, Larsson N, Leveén P, Ehinger M, Nilsson E, Karlsson S.

Blood. 2004 Jun 1;103(11):4126-33. Epub 2004 Feb 12.

13.

[Effect of Curcumin on TGF-β2 Regulated PPAR-γ/PDGF-β Signaling Pathway in Lung Fibroblasts of Mice].

Gond L, Liu DS, Lin J, Wu Y, Zhu HL.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Oct;35(10):1249-54. Chinese.

PMID:
26677679
14.

PRDM16 controls a brown fat/skeletal muscle switch.

Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scimè A, Devarakonda S, Conroe HM, Erdjument-Bromage H, Tempst P, Rudnicki MA, Beier DR, Spiegelman BM.

Nature. 2008 Aug 21;454(7207):961-7. doi: 10.1038/nature07182.

15.

A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development.

Hadland BK, Huppert SS, Kanungo J, Xue Y, Jiang R, Gridley T, Conlon RA, Cheng AM, Kopan R, Longmore GD.

Blood. 2004 Nov 15;104(10):3097-105. Epub 2004 Jul 13.

18.

Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.

Kikushige Y, Yoshimoto G, Miyamoto T, Iino T, Mori Y, Iwasaki H, Niiro H, Takenaka K, Nagafuji K, Harada M, Ishikawa F, Akashi K.

J Immunol. 2008 Jun 1;180(11):7358-67.

19.
20.

New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.

Lafont J, Jacques C, Le Dreau G, Calhabeu F, Thibout H, Dubois C, Berenbaum F, Laurent M, Martinerie C.

J Bone Miner Res. 2005 Dec;20(12):2213-23. Epub 2005 Aug 22. Erratum in: J Bone Miner Res. 2006 Feb;21(2):352.

Supplemental Content

Support Center